Peripheral non-viral MIDGE vector-driven delivery of β-endorphin in inflammatory pain

<p>Abstract</p> <p>Background</p> <p>Leukocytes infiltrating inflamed tissue produce and release opioid peptides such as β-endorphin, which activate opioid receptors on peripheral terminals of sensory nerves resulting in analgesia. Gene therapy is an attractive strategy...

Full description

Saved in:
Bibliographic Details
Main Authors: Busch Melanie (Author), Labuz Dominika (Author), Brack Alexander (Author), Rittner Heike L (Author), Mousa Shaaban A (Author), Sitte Nicolle (Author), Binder Waltraud (Author), Schroff Matthias (Author), Oswald Detlef (Author), Machelska Halina (Author), Wittig Burghardt (Author), Schäfer Michael (Author), Stein Christoph (Author)
Format: Book
Published: SAGE Publishing, 2009-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_78cde4651a344d328d838e6b64a98de2
042 |a dc 
100 1 0 |a Busch Melanie  |e author 
700 1 0 |a Labuz Dominika  |e author 
700 1 0 |a Brack Alexander  |e author 
700 1 0 |a Rittner Heike L  |e author 
700 1 0 |a Mousa Shaaban A  |e author 
700 1 0 |a Sitte Nicolle  |e author 
700 1 0 |a Binder Waltraud  |e author 
700 1 0 |a Schroff Matthias  |e author 
700 1 0 |a Oswald Detlef  |e author 
700 1 0 |a Machelska Halina  |e author 
700 1 0 |a Wittig Burghardt  |e author 
700 1 0 |a Schäfer Michael  |e author 
700 1 0 |a Stein Christoph  |e author 
245 0 0 |a Peripheral non-viral MIDGE vector-driven delivery of β-endorphin in inflammatory pain 
260 |b SAGE Publishing,   |c 2009-12-01T00:00:00Z. 
500 |a 10.1186/1744-8069-5-72 
500 |a 1744-8069 
520 |a <p>Abstract</p> <p>Background</p> <p>Leukocytes infiltrating inflamed tissue produce and release opioid peptides such as β-endorphin, which activate opioid receptors on peripheral terminals of sensory nerves resulting in analgesia. Gene therapy is an attractive strategy to enhance continuous production of endogenous opioids. However, classical viral and plasmid vectors for gene delivery are hampered by immunogenicity, recombination, oncogene activation, anti-bacterial antibody production or changes in physiological gene expression. Non-viral, non-plasmid minimalistic, immunologically defined gene expression (MIDGE) vectors may overcome these problems as they carry only elements needed for gene transfer. Here, we investigated the effects of a nuclear localization sequence (NLS)-coupled MIDGE encoding the β-endorphin precursor proopiomelanocortin (POMC) on complete Freund's adjuvant-induced inflammatory pain in rats.</p> <p>Results</p> <p>POMC-MIDGE-NLS injected into inflamed paws appeared to be taken up by leukocytes resulting in higher concentrations of β-endorphin in these cells. POMC-MIDGE-NLS treatment reversed enhanced mechanical sensitivity compared with control MIDGE-NLS. However, both effects were moderate, not always statistically significant or directly correlated with each other. Also, the anti-hyperalgesic actions could not be increased by enhancing β-endorphin secretion or by modifying POMC-MIDGE-NLS to code for multiple copies of β-endorphin.</p> <p>Conclusion</p> <p>Although MIDGE vectors circumvent side-effects associated with classical viral and plasmid vectors, the current POMC-MIDGE-NLS did not result in reliable analgesic effectiveness in our pain model. This was possibly associated with insufficient and variable efficacy in transfection and/or β-endorphin production. Our data point at the importance of the reproducibility of gene therapy strategies for the control of chronic pain.</p> 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Molecular Pain, Vol 5, Iss 1, p 72 (2009) 
787 0 |n http://www.molecularpain.com/content/5/1/72 
787 0 |n https://doaj.org/toc/1744-8069 
856 4 1 |u https://doaj.org/article/78cde4651a344d328d838e6b64a98de2  |z Connect to this object online.